Complement Therapeutics
Clinical trials sponsored by Complement Therapeutics, explained in plain language.
-
One-Shot eye injection aims to halt blinding disease
Disease control Recruiting nowThis study is testing a new, one-time injection called CTx001 for people with geographic atrophy, a severe form of age-related macular degeneration that causes permanent vision loss. The main goals are to see if the injection is safe and if it can slow down the damage to the reti…
Phase: PHASE1, PHASE2 • Sponsor: Complement Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists track eye disease progression in real time
Knowledge-focused Recruiting nowThis observational study aims to better understand how geographic atrophy, a form of advanced age-related macular degeneration, progresses over a short period. Researchers will follow 75 participants aged 55 and older who have this condition in both eyes, using eye scans and visi…
Sponsor: Complement Therapeutics • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC